Literature DB >> 2926241

Characterization of a novel myeloma cell line, MM.1.

R E Goldman-Leikin1, H R Salwen, C V Herst, D Variakojis, M L Bian, M M Le Beau, P Selvanayagan, R Marder, R Anderson, S Weitzman.   

Abstract

A myeloma cell line, MM.1, has been established from the peripheral blood cells of a patient with immunoglobulin A myeloma. MM.1 grows in suspension either singly or in small clusters and secretes lambda-light chain. Phenotypically, MM.1 cells lack most B cell antigens, but they do express human leukocyte antigen DR, PCA-1, and T9 and T10 antigens. Molecular analysis of MM.1 demonstrates that it is negative for the presence of the Epstein-Barr virus genome. Southern analysis of MM.1 detected a rearrangement of the lambda-light chain gene, and Northern analysis revealed high levels of lambda gene expression. Cytogenetic analysis of the MM.1 cell line revealed the presence of seven related chromosomally abnormal cell lines characterized by numerical and structural aberrations, and it revealed five nonclonal abnormal cells. The most notable abnormality is a reciprocal translocation involving band q24.3 of chromosome 12 and band q32.3 of chromosome 14; translocations involving 14q32 are frequently observed in neoplasms of B cell origin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2926241

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  19 in total

1.  Optical techniques for tracking multiple myeloma engraftment, growth, and response to therapy.

Authors:  Judith M Runnels; Alicia L Carlson; Costas Pitsillides; Brian Thompson; Juwell Wu; Joel A Spencer; John M J Kohler; AbdelKareem Azab; Anne-Sophie Moreau; Scott J Rodig; Andrew L Kung; Kenneth C Anderson; Irene M Ghobrial; Charles P Lin
Journal:  J Biomed Opt       Date:  2011 Jan-Feb       Impact factor: 3.170

2.  Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1.

Authors:  Ajaikumar B Kunnumakkara; Asha S Nair; Bokyung Sung; Manoj K Pandey; Bharat B Aggarwal
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

3.  8-Amino-adenosine inhibits multiple mechanisms of transcription.

Authors:  Jennifer Ann Frey; Varsha Gandhi
Journal:  Mol Cancer Ther       Date:  2010-01-06       Impact factor: 6.261

4.  High levels of tRNA abundance and alteration of tRNA charging by bortezomib in multiple myeloma.

Authors:  Ying Zhou; Jeffrey M Goodenbour; Lucy A Godley; Amittha Wickrema; Tao Pan
Journal:  Biochem Biophys Res Commun       Date:  2009-05-19       Impact factor: 3.575

5.  Glucocorticoid resistance in a multiple myeloma cell line is regulated by a transcription elongation block in the glucocorticoid receptor gene (NR3C1).

Authors:  Beatriz Sánchez-Vega; Varsha Gandhi
Journal:  Br J Haematol       Date:  2008-12-26       Impact factor: 6.998

6.  Dual regulation of glucocorticoid-induced leucine zipper (GILZ) by the glucocorticoid receptor and the PI3-kinase/AKT pathways in multiple myeloma.

Authors:  Katharine D Grugan; Chunguang Ma; Seema Singhal; Nancy L Krett; Steven T Rosen
Journal:  J Steroid Biochem Mol Biol       Date:  2008-04-20       Impact factor: 4.292

7.  Mechanistic Studies of the Multiple Myeloma and Melanoma Cell-Selective Toxicity of the Rpn13-Binding Peptoid KDT-11.

Authors:  Paige Dickson; Scott Simanski; John Maina Ngundu; Thomas Kodadek
Journal:  Cell Chem Biol       Date:  2020-08-27       Impact factor: 8.116

8.  Predicting PD-L1 expression on human cancer cells using next-generation sequencing information in computational simulation models.

Authors:  Emily A Lanzel; M Paula Gomez Hernandez; Amber M Bates; Christopher N Treinen; Emily E Starman; Carol L Fischer; Deepak Parashar; Janet M Guthmiller; Georgia K Johnson; Taher Abbasi; Shireen Vali; Kim A Brogden
Journal:  Cancer Immunol Immunother       Date:  2016-09-29       Impact factor: 6.968

9.  Characterization of multiple myeloma vesicles by label-free relative quantitation.

Authors:  Sean W Harshman; Alessandro Canella; Paul D Ciarlariello; Alberto Rocci; Kitty Agarwal; Emily M Smith; Tiffany Talabere; Yvonne A Efebera; Craig C Hofmeister; Don M Benson; Michael E Paulaitis; Michael A Freitas; Flavia Pichiorri
Journal:  Proteomics       Date:  2013-10       Impact factor: 3.984

10.  Inhibition of ATP synthase by chlorinated adenosine analogue.

Authors:  Lisa S Chen; Billie J Nowak; Mary L Ayres; Nancy L Krett; Steven T Rosen; Shuxing Zhang; Varsha Gandhi
Journal:  Biochem Pharmacol       Date:  2009-05-27       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.